CEPT inhibition

Anacetrapib      

pathologytreatmentpatient Demonstrated benefit and harm k      
cardiovascular preventionanacetrapibnot classified

versus

No demonstrated result for efficacy

1 trialmeta-analysis
cardiovascular preventionanacetrapibnot classified

versus placebo

No demonstrated result for efficacy

1 trialmeta-analysis
cardiovascular preventiontorcetrapibnot classified

versus placebo

No demonstrated result for efficacy

torcetrapib inferior to placebo in terms of all cause death in ILLUMINATE, 2007

torcetrapib inferior to placebo in terms of Coronary revascularization in ILLUMINATE, 2007

4 trialsmeta-analysis